Shenzhen Historical Income Statement
| 300942 Stock | 8.48 0.50 5.57% |
Historical analysis of Shenzhen Bioeasy income statement accounts such as Interest Expense of 11.2 M, Selling General Administrative of 76.7 M or Total Revenue of 373.8 M can show how well Shenzhen Bioeasy Biotechnology performed in making a profits. Evaluating Shenzhen Bioeasy income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Shenzhen Bioeasy's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Shenzhen Bioeasy Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Shenzhen Bioeasy Bio is a good buy for the upcoming year.
Shenzhen |
About Shenzhen Income Statement Analysis
Shenzhen Bioeasy Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Shenzhen Bioeasy shareholders. The income statement also shows Shenzhen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Shenzhen Bioeasy Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Shenzhen Bioeasy Bio generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Shenzhen Bioeasy Biotechnology minus its cost of goods sold. It is profit before Shenzhen Bioeasy operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most accounts from Shenzhen Bioeasy's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Shenzhen Bioeasy Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shenzhen Bioeasy Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Shenzhen Bioeasy's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 11.2 M, whereas Selling General Administrative is forecasted to decline to about 76.7 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 5.3M | 4.1M | 10.6M | 11.2M | Tax Provision | 31.6M | 12.2M | 7.2M | 14.0M |
Shenzhen Bioeasy income statement Correlations
Click cells to compare fundamentals
Shenzhen Bioeasy Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Shenzhen Bioeasy income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | 13.7M | 8.5M | 31.6M | 12.2M | 7.2M | 14.0M | |
| Interest Expense | 949.8K | 10.6M | 5.3M | 4.1M | 10.6M | 11.2M | |
| Selling General Administrative | 58.9M | 72.8M | 99.7M | 89.1M | 80.5M | 76.7M | |
| Total Revenue | 239.2M | 258.5M | 597.5M | 686.9M | 254.1M | 373.8M | |
| Gross Profit | 173.1M | 181.7M | 426.2M | 388.1M | 126.9M | 242.0M | |
| Operating Income | 105.2M | 75.1M | 268.3M | 137.7M | (66.9M) | (63.5M) | |
| Cost Of Revenue | 66.1M | 76.7M | 171.4M | 298.8M | 127.2M | 131.8M | |
| Income Before Tax | 106.0M | 73.9M | 268.0M | 94.9M | (177.8M) | (168.9M) | |
| Net Income Applicable To Common Shares | 73.9M | 92.3M | 65.4M | 236.5M | 272.0M | 285.6M | |
| Net Income | 92.3M | 65.4M | 236.5M | 83.0M | (184.9M) | (175.7M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Shenzhen Stock
Shenzhen Bioeasy Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Shenzhen Bioeasy shareholders. The income statement also shows Shenzhen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).